ReviewRegenerative biomaterials2026
The next generation of alginate dressings: recent innovations for chronic wound healing.
Review in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Marine-Derived Polysaccharide Nanofibers for Wound Healing: Mechanistic Rationale, Biofabrication Strategies, and Translational Barriers.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic wounds remain a major clinical challenge with a huge associated socioeconomic burden. Therefore, multifunctional biomaterials that can simultaneously manage exudate, modulate inflammation, prevent infection and promote tissue regeneration are extremely needed. Alginate, a naturally derived and highly biocompatible polysaccharide, has long been used in the clinic for advanced wound care due to its intrinsic gel-forming ability and capacity to maintain a moist healing environment. However, commercially available products are primarily designed to absorb exudate and physically protect the wound, while offering limited support for other key therapeutic goals, including modulation of inflammation and stimulation of tissue repair and regeneration. This review highlights the most recent innovations aimed at enhancing alginate's therapeutic potential, either through physicochemical modifications of hydrogels or by expanding beyond traditional hydrogel formats into novel alginate architectures that offer improved tissue integration, tunability and controlled release of substances. The review also outlines synergistic formulations combining alginate with other biomaterials, bioactive molecules and cell-derived products to enhance its mechanical properties and antimicrobial performance, as well as to address immunomodulation and promote regeneration in chronic wounds. Together, these emerging approaches underscore alginate's versatility and potential as a multifunctional platform for next-generation chronic wound therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.